Maximum quantity allowed is 999
请选择数量
CAS RN: 124750-99-8 | 产品编码: L0232
Losartan Potassium

技术规格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
物性(参考值)
GHS
相关法规
RTECS# | NI6755100 |
运输信息
HS编码* | 2933.29-000 |
应用
Losartan Potassium: A Water-Soluble, Reversible and Non-Competitive Antagonist of the AT1 Receptor
Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE). Angiotensin II is a potent vasoconstrictor, and an important component in the pathophysiology of hypertension. Angiotensin II can activate two different receptors, AT1 and AT2. The most important vasoconstrictor action of angiotensin II are mediate trough AT1 receptors. Losartan [L0378] is a prodrug, and its active metabolite (EXP3174) works as a reversible, non-competitive antagonist of the AT1 receptor.1,2) In addition, neither losartan nor its active metabolite inhibits ACE nor do they bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation. In clinical, its water-soluble potassium salt (DUP 753) is used for the treatment of hypertension. Recently, AT1 receptor antagonists (blockers), such as losartan, are expected as therapeutics for reducing the aggressiveness and mortality from SARS-CoV-2 virus infections.3) (The product is for research purpose only.)
References
- 1) Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent
- 2) Losartan potassium: A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension
- 3) Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics (a review)
参考文献
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。